Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging

This publication has 46 references indexed in Scilit:

• Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease
  Annals of Oncology, 2003
• Positron emission tomography imaging in nonmalignant thoracic disorders
  Seminars in Nuclear Medicine, 2002
• 23. Localization and reduction of FDG intestinal uptake: tissue distribution and autoradiography study
  Nuclear Medicine Communications, 2002
• Effect of Atropine and Sincalide on the Intestinal Uptake of F-18 Fluorodeoxyglucose
  Clinical Nuclear Medicine, 1999
• Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• Increased FDG uptake in the wall of the right atrium in people who participated in a cancer screening program with whole-body PET
  Annals of Nuclear Medicine, 1999
• Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants
  RadioGraphics, 1999
• A PET study of 18 FDG uptake in soft tissue masses
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation
  Seminars in Nuclear Medicine, 1996